Home » New Hair Loss Treatments Pipeline
Share on Facebook | Share on Google+ | Share on Twitter
The following technologies, treatments, and devices are currently being studied by legitimate institutions, companies, and research facilities. The goal with each is to treat and cure hair loss in all its forms. This page will be updated on a regular basis, along with corresponding articles describing progress in the months to come.
View program page
You can click each of the icons above to view a page dedicated to each project. Below we summarize the updates found on each of those pages, related to each of the project. You can either bookmark this main Pipeline page or the individual pages.
09-27-16: Hair Primordiums Research Status Update: Interview with Organ Technologies
Interview with Organ Technologies, CEO and one of the lead researchers on Dr. Tsuji’s team, presenting the latest updates on the project status, timelines, and future plans for commercialization.
07-01-16: Hair Follicle Regeneration Research Project – Riken
The page dedicated to the project on the Riken website. Learn about the science behind hair primordiums, and the methods by which Dr. Tsuji and his team at Organ Technologies hopes to make hair primordiums the next revolutionary hair regeneration treatment.
07-26-16: Kyocera to Begin Regenerative Hair Loss Treatment Research
HairLossTalk’s introductory article presenting the Hair Primordiums research project, and the partnership between Riken and Organ Technologies with funding from Kyocera.
08-11-16: Shiseido to Begin Cell Hair Regeneration Trial
HairLossTalk’s article presenting the Shiseido RCH01 Research Project. It is a form of autologous cell therapy based on dermal sheath cup cells. Article goes into Replicel’s partnering with and licensing of the technology to Shiseido as well as the two different markets they’re developing the treatment for.
09-29-16: Histogen Signs Deal with China Distributor
Histogen has signed a deal for development and commercialization of Hair Stimulating Complex with an important pharmaceutical partner in mainland china…
08-18-16: Interview with Dr. Gail Naughton – Status update on HSC Research
Interview with Dr. Gail Naughton and Eileen Brandt discussing the current status of new hair loss treatment “HSC”, and upcoming plans for future trials…
08-15-16: Histogen Secures $6m Investment
Histogen has received $6 million in funding to support the development and continued research of their Hair Stimulating Complex (HSC) product research…
Project Updates: Coming Soon.
10-01-16: Samumed Includes Hair Loss in Regenerative Medicine PlatformPresentation by Samumed CEO on its SM04554 hair regeneration project using Wnt signaling to control the effects of aging on tissues. Results from the Phase 1 and Phase 2 trials can be found in here including links to the study results, informative videos, and and interesting story as well.
09-19-16: New Study Confirms JAK3 Effective in Alopecia Areata
This article presents an overview of the ongoing work being done by Dr. Angela Christiano and JAK3 inhibitors in the treatment of Alopecia Areata, as well as their potential use as a treatment for Androgenetic Alopecia.
09-18-16: Alopecia Areata Cure? Aclaris Therapeutics JAK3 Inhibitors.
The discovery of a topical and oral treatment shown to completely reverse the effects of Alopecia Areata and possibly Male Pattern Baldness.